Laboratorios Farmaceuticos Rovi, S.A. (BME: ROVI)

BME: ROVI Revenue

Laboratorios Farmaceuticos Rovi had revenue of 235.28M EUR in the quarter ending September 30, 2024, with 9.93% growth. This brings the company's revenue in the last twelve months to 799.25M, down -4.52% year-over-year. In the year 2023, Laboratorios Farmaceuticos Rovi had annual revenue of 829.51M with 1.44% growth.

• Revenue (ttm): 799.25M
• Revenue Growth: -4.52%
• P/S Ratio: 4.10
• Revenue / Employee: 378.61K
• Employees: 2,111
• Market Cap: 3.14B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	829.51M	11.81M	1.44%
Dec 31, 2022	817.70M	169.02M	26.06%
Dec 31, 2021	648.68M	228.72M	54.46%
Dec 31, 2020	419.96M	38.65M	10.14%
Dec 31, 2019	381.31M	78.11M	25.76%